![Hassan Javanbakht](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hassan Javanbakht
Technik-/Wissenschafts-/F&E-Leiter bei
MIRUM PHARMACEUTICALS, INC.
Profil
Hassan Javanbakht is currently Chief Scientific Officer at Mirum Pharmaceuticals, Inc. Formerly, Chief Scientific Officer at Bluejay Therapeutics, Inc. Education includes a doctorate from McGill University.
Aktive Positionen von Hassan Javanbakht
| Unternehmen | Position | Beginn |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2026 |
Ehemalige bekannte Positionen von Hassan Javanbakht
| Unternehmen | Position | Ende |
|---|---|---|
Bluejay Therapeutics, Inc.
 Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Hassan Javanbakht
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Health Technology |
